These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 24900272)
21. Protein tyrosine phosphatases: Ligand interaction analysis and optimisation of virtual screening. Ghattas MA; Atatreh N; Bichenkova EV; Bryce RA J Mol Graph Model; 2014 Jul; 52():114-23. PubMed ID: 25038507 [TBL] [Abstract][Full Text] [Related]
22. Pd-catalyzed direct C-H bond functionalization of spirocyclic σ1 ligands: generation of a pharmacophore model and analysis of the reverse binding mode by docking into a 3D homology model of the σ1 receptor. Meyer C; Schepmann D; Yanagisawa S; Yamaguchi J; Dal Col V; Laurini E; Itami K; Pricl S; Wünsch B J Med Chem; 2012 Sep; 55(18):8047-65. PubMed ID: 22913577 [TBL] [Abstract][Full Text] [Related]
23. Benchmarking GPCR homology model template selection in combination with de novo loop generation. Szwabowski GL; Castleman PN; Sears CK; Wink LH; Cole JA; Baker DL; Parrill AL J Comput Aided Mol Des; 2020 Oct; 34(10):1027-1044. PubMed ID: 32737667 [TBL] [Abstract][Full Text] [Related]
24. Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models. Vilar S; Ferino G; Phatak SS; Berk B; Cavasotto CN; Costanzi S J Mol Graph Model; 2011 Feb; 29(5):614-23. PubMed ID: 21146435 [TBL] [Abstract][Full Text] [Related]
25. Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis. Ren JX; Zhang RT; Zhang H Molecules; 2020 Mar; 25(5):. PubMed ID: 32131468 [TBL] [Abstract][Full Text] [Related]
26. Structure selection for protein kinase docking and virtual screening: homology models or crystal structures? Rockey WM; Elcock AH Curr Protein Pept Sci; 2006 Oct; 7(5):437-57. PubMed ID: 17073695 [TBL] [Abstract][Full Text] [Related]
27. 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity. Oluić J; Nikolic K; Vucicevic J; Gagic Z; Filipic S; Agbaba D Comb Chem High Throughput Screen; 2017 Aug; 20(4):292-303. PubMed ID: 28460621 [TBL] [Abstract][Full Text] [Related]
28. Computational approaches for protein function prediction: a combined strategy from multiple sequence alignment to molecular docking-based virtual screening. Pierri CL; Parisi G; Porcelli V Biochim Biophys Acta; 2010 Sep; 1804(9):1695-712. PubMed ID: 20433957 [TBL] [Abstract][Full Text] [Related]
29. A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α. Perricone U; Wieder M; Seidel T; Langer T; Padova A; Almerico AM; Tutone M ChemMedChem; 2017 Aug; 12(16):1399-1407. PubMed ID: 28135036 [TBL] [Abstract][Full Text] [Related]
30. In silico approaches to identify novel myeloid cell leukemia-1 (Mcl-1) inhibitors for treatment of cancer. Ren JX; Li CP; Zhou XL; Cao XS; Xie Y J Biomol Struct Dyn; 2018 Jul; 36(9):2424-2435. PubMed ID: 28714799 [TBL] [Abstract][Full Text] [Related]
31. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors. Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133 [TBL] [Abstract][Full Text] [Related]
32. A benchmarking study on virtual ligand screening against homology models of human GPCRs. Lim VJY; Du W; Chen YZ; Fan H Proteins; 2018 Sep; 86(9):978-989. PubMed ID: 30051928 [TBL] [Abstract][Full Text] [Related]
33. E-pharmacophore-based virtual screening to identify GSK-3β inhibitors. Natarajan P; Priyadarshini V; Pradhan D; Manne M; Swargam S; Kanipakam H; Bhuma V; Amineni U J Recept Signal Transduct Res; 2016 Oct; 36(5):445-58. PubMed ID: 27305963 [TBL] [Abstract][Full Text] [Related]
34. Another brick in the wall. Validation of the σ1 receptor 3D model by computer-assisted design, synthesis, and activity of new σ1 ligands. Laurini E; Marson D; Dal Col V; Fermeglia M; Mamolo MG; Zampieri D; Vio L; Pricl S Mol Pharm; 2012 Nov; 9(11):3107-26. PubMed ID: 23020867 [TBL] [Abstract][Full Text] [Related]
35. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study. Choubey SK; Jeyaraman J J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885 [TBL] [Abstract][Full Text] [Related]
36. QSAR modeling, pharmacophore-based virtual screening, and ensemble docking insights into predicting potential epigallocatechin gallate (EGCG) analogs against epidermal growth factor receptor. Bommu UD; Konidala KK; Pabbaraju N; Yeguvapalli S J Recept Signal Transduct Res; 2019 Feb; 39(1):18-27. PubMed ID: 31223050 [TBL] [Abstract][Full Text] [Related]
37. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors. Bhunia SS; Saxena AK Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584 [TBL] [Abstract][Full Text] [Related]
38. SPOT-Ligand: Fast and effective structure-based virtual screening by binding homology search according to ligand and receptor similarity. Yang Y; Zhan J; Zhou Y J Comput Chem; 2016 Jul; 37(18):1734-9. PubMed ID: 27074979 [TBL] [Abstract][Full Text] [Related]
39. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification. Islam MA; Pillay TS J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527 [TBL] [Abstract][Full Text] [Related]
40. Assessing GPCR homology models constructed from templates of various transmembrane sequence identities: Binding mode prediction and docking enrichment. Loo JSE; Emtage AL; Ng KW; Yong ASJ; Doughty SW J Mol Graph Model; 2018 Mar; 80():38-47. PubMed ID: 29306746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]